RESUMEN
Alzheimer's disease (AD) and Diabetes mellitus (DM) exhibit comparable pathophysiological pathways. Genetic abnormalities in APP, PS-1, and PS-2 are linked to AD, with diagnostic aid from CSF and blood biomarkers. Insulin dysfunction, termed "type 3 diabetes mellitus" in AD, involves altered insulin signalling and neuronal shrinkage. Insulin influences beta-amyloid metabolism, exacerbating neurotoxicity in AD and amyloid production in DM. Both disorders display impaired glucose transporter expression, hastening cognitive decline. Mitochondrial dysfunction and Toll-like receptor 4-mediated inflammation worsen neurodegeneration in both diseases. ApoE4 raises disease risk, especially when coupled with dyslipidemia common in DM. Targeting shared pathways like insulin-degrading enzyme activation and HSP60 holds promise for therapeutic intervention. Recognizing these interconnected mechanisms underscores the imperative for developing tailored treatments addressing the overlapping pathophysiology of AD and DM, offering potential avenues for more effective management of both conditions.
Asunto(s)
Enfermedad de Alzheimer , Humanos , Enfermedad de Alzheimer/metabolismo , Diabetes Mellitus/metabolismo , AnimalesRESUMEN
This study investigated the factors responsible for migration and homing of magnetically labeled AC133(+) cells at the sites of active angiogenesis in tumor. AC133(+) cells labeled with ferumoxide-protamine sulfate were mixed with either rat glioma or human melanoma cells and implanted in flank of nude mice. An MRI of the tumors including surrounding tissues was performed. Tumor sections were stained for Prussian blue (PB), platelet-derived growth factor (PDGF), hypoxia-inducible factor-1alpha (HIF-1alpha), stromal cell derived factor-1 (SDF-1), matrix metalloproteinase-2 (MMP-2), vascular endothelial growth factor (VEGF), and endothelial markers. Fresh snap-frozen strips from the central and peripheral parts of the tumor were collected for Western blotting. MRIs demonstrated hypointense regions at the periphery of the tumors where the PB(+)/AC133(+) cells were positive for endothelial cells markers. At the sites of PB(+)/AC133(+) cells, both HIF-1alpha and SDF-1 were strongly positive and PDGF and MMP-2 showed generalized expression in the tumor and surrounding tissues. There was no significant association of PB(+)/AC133(+) cell localization and VEGF expression in tumor cells. Western blot demonstrated strong expression of the SDF-1, MMP-2, and PDGF at the peripheral parts of the tumors. HIF-1alpha was expressed at both the periphery and central parts of the tumor. This work demonstrates that magnetically labeled cells can be used as probes for MRI and histological identification of administered cells.
Asunto(s)
Movimiento Celular , Movilización de Célula Madre Hematopoyética , Trasplante de Células Madre Mesenquimatosas , Neovascularización Patológica/patología , Antígeno AC133 , Animales , Antígenos CD/metabolismo , Hipoxia de la Célula/fisiología , Línea Celular Tumoral , Quimiocina CXCL12/biosíntesis , Dextranos , Femenino , Óxido Ferrosoférrico , Glioma/patología , Glicoproteínas/metabolismo , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/biosíntesis , Hierro , Imagen por Resonancia Magnética/métodos , Nanopartículas de Magnetita , Metaloproteinasa 2 de la Matriz/biosíntesis , Melanoma Amelanótico/patología , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Trasplante de Neoplasias , Óxidos , Péptidos/metabolismo , Factor de Crecimiento Derivado de Plaquetas/biosíntesis , Protaminas , Ratas , Factor A de Crecimiento Endotelial Vascular/biosíntesisRESUMEN
This article along with the first 2 in this series (4,12) completes the discussion on the key molecules and process inside the cell namely, DNA, RNA, and proteins. These 3 articles provide a very basic foundation for understanding molecular biology concepts and summarize some of the work of numerous scientists over the past century. We understand these processes far better now than we did in the past, but clearly this knowledge is by no means complete and a number of basic scientists are working hard to elucidate and understand the fundamental mechanisms that operate within a cell. Genes and gene products work with each other in complex, interconnected pathways, and in perfect harmony to make a functional cell, tissue, and an organism as a whole. There is a lot of cross-talk that happens between different proteins that interact with various other proteins, DNA, and RNA to establish pathways, networks, and molecular systems as a team working to perfection. The past 15 years have seen the rapid development of systems biology approaches. We live in an era that emphasizes multi-disciplinary, cross-functional teams to perform science rather than individual researchers working on the bench on a very specific problem. Global approaches have become more common and the amount of data generated must be managed by trained bioinformatics personnel and large computers. In our subsequent articles, we will discuss these global approaches and the areas of genomics, functional genomics, and proteomics that have revolutionized the way we perform science.
Asunto(s)
Biología Molecular , Proteínas/química , Estructura Molecular , VocabularioRESUMEN
The process of gene expression is complex and highly regulated to ensure that the right gene is expressed at the right place, at the right time, and in regulated amounts. The cell has multiple levels at which it controls the expression of a transcript including gene expression, alternate splicing, and stability of the transcript. Alternate splicing to generate different RNA species from a given gene and DNA rearrangements where genes are rearranged during cellular differentiation (eg, immunoglobulin genes) are additional mechanisms used to generate diversity in complex organisms. Epigenetic mechanisms such as methylation where CpG-rich islands in the promoter region depending on their methylation status can also modulate gene expression. The reader is requested to refer to the books, review articles, and web sites for additional information.
Asunto(s)
Expresión Génica , Transcripción Genética , Empalme Alternativo/genética , Islas de CpG , Metilación de ADN , Epigénesis Genética , Expresión Génica/genética , Humanos , Biología Molecular , ARN/clasificación , ARN/genética , Procesamiento Postranscripcional del ARN/genética , Transcripción Genética/genéticaAsunto(s)
Genómica , Biología Molecular , Genética Médica , Humanos , Mapeo Físico de Cromosoma , Análisis de SecuenciaAsunto(s)
ADN , ADN/química , Replicación del ADN/fisiología , Código Genético , Genoma , Humanos , Biología Molecular , VocabularioRESUMEN
Ferumoxides-protamine sulfate (FE-Pro) complexes are used for intracellular magnetic labeling of cells to non-invasively monitor cell trafficking by in vivo MRI. FE-Pro labeling is non-toxic to cells; however, the effects of FE-Pro labeling on cellular expression of transferrin receptor (TfR-1) and ferritin, proteins involved in iron transport and storage, has not been reported. FE-Pro-labeled human mesenchymal stem cells (MSCs), HeLa cells and primary macrophages were cultured from 1 week to 2 months and evaluated for TfR-1 and ferritin gene expression by RT-PCR and protein levels were determined using Western blots. MTT (proliferation assay) and reactive oxygen species (ROS) analysis were performed. FE-Pro labeling of HeLa and MSCs resulted in a transient decrease in TfR-1 mRNA and protein levels. In contrast, Fe-Pro labeling of primary macrophages resulted in an increase in TfR-1 mRNA but not in TfR-1 protein levels. Ferritin mRNA and protein levels increased transiently in labeled HeLa and macrophages but were sustained in MSCs. No changes in MTT and ROS analysis were noted. In conclusion, FE-Pro labeling elicited physiological changes of iron metabolism or storage, validating the safety of this procedure for cellular tracking by MRI.
Asunto(s)
Ferritinas/metabolismo , Hierro/metabolismo , Imagen por Resonancia Magnética/métodos , Óxidos/metabolismo , Protaminas/metabolismo , Receptores de Transferrina/metabolismo , Diferenciación Celular , Proliferación Celular , Supervivencia Celular , Células Cultivadas , Dextranos , Ferritinas/genética , Óxido Ferrosoférrico , Células HeLa , Humanos , Indicadores y Reactivos/metabolismo , Macrófagos/citología , Macrófagos/metabolismo , Nanopartículas de Magnetita , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Receptores de Transferrina/genéticaRESUMEN
UNLABELLED: AC133 cells, a subpopulation of CD34+ hematopoietic stem cells, can transform into endothelial cells that may integrate into the neovasculature of tumors or ischemic tissue. Most current imaging modalities do not allow monitoring of early migration and incorporation of endothelial progenitor cells (EPCs) into tumor neovasculature. The goals of this study were to use magnetic resonance imaging (MRI) to track the migration and incorporation of intravenously injected, magnetically labeled EPCs into the blood vessels in a rapidly growing flank tumor model and to determine whether the pattern of EPC incorporation is related to the time of injection or tumor size. MATERIALS AND METHODS: EPCs labeled with ferumoxide-protamine sulfate (FePro) complexes were injected into mice bearing xenografted glioma, and MRI was obtained at different stages of tumor development and size. RESULTS: Migration and incorporation of labeled EPCs into tumor neovasculature were detected as low signal intensity on MRI at the tumor periphery as early as 3 days after EPC administration in preformed tumors. However, low signal intensities were not observed in tumors implanted at the time of EPC administration until tumor size reached 1 cm at 12 to 14 days. Prussian blue staining showed iron-positive cells at the sites corresponding to low signal intensity on MRI. Confocal microscopy showed incorporation into the neovasculature, and immunohistochemistry clearly demonstrated the transformation of the administered EPCs into endothelial cells. CONCLUSION: MRI demonstrated the incorporation of FePro-labeled human CD34+/AC133+ EPCs into the neovasculature of implanted flank tumors.
Asunto(s)
Movimiento Celular , Glioma/metabolismo , Células Madre Hematopoyéticas/metabolismo , Angiografía por Resonancia Magnética , Neovascularización Patológica/metabolismo , Antígeno AC133 , Animales , Antígenos CD , Antígenos CD34 , Línea Celular , Medios de Contraste/farmacología , Dextranos , Femenino , Óxido Ferrosoférrico , Glioma/patología , Glicoproteínas , Células Madre Hematopoyéticas/patología , Humanos , Hierro/farmacología , Angiografía por Resonancia Magnética/métodos , Nanopartículas de Magnetita , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Microscopía Confocal/métodos , Neoplasias Experimentales/metabolismo , Neoplasias Experimentales/patología , Neovascularización Patológica/patología , Óxidos/farmacología , PéptidosRESUMEN
The purpose of this article is to explore how molecular imaging techniques can be used as useful adjunts in the development of "nanomedicine" and in personalizing treatment of patients. The discussion focuses on in vivo applications at the whole organism level even though imaging can also play an important role in research at the cellular and subcellular level.
Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Ciencia del Laboratorio Clínico/métodos , Técnicas de Diagnóstico Molecular/métodos , Nanotecnología/métodos , Neoplasias/diagnóstico , Neoplasias/tratamiento farmacológico , Tomografía Computarizada de Emisión/métodos , Antineoplásicos/uso terapéutico , Diagnóstico por Imagen/instrumentación , Diagnóstico por Imagen/métodos , Sistemas de Liberación de Medicamentos/instrumentación , Humanos , Ciencia del Laboratorio Clínico/instrumentación , Técnicas de Sonda Molecular , Sondas Moleculares , Nanotecnología/instrumentación , Neoplasias/diagnóstico por imagen , Tomografía Computarizada de Emisión/instrumentaciónRESUMEN
Asthma is a common respiratory disorder characterized by recurrent episodes of coughing, wheezing and breathlessness. Although environmental factors such as allergen exposure are risk factors in the development of asthma, both twin and family studies point to a strong genetic component. To date, linkage studies have identified more than a dozen genomic regions linked to asthma. In this study, we performed a genome-wide scan on 460 Caucasian families and identified a locus on chromosome 20p13 that was linked to asthma (log(10) of the likelihood ratio (LOD), 2.94) and bronchial hyperresponsiveness (LOD, 3.93). A survey of 135 polymorphisms in 23 genes identified the ADAM33 gene as being significantly associated with asthma using case-control, transmission disequilibrium and haplotype analyses (P = 0.04 0.000003). ADAM proteins are membrane-anchored metalloproteases with diverse functions, which include the shedding of cell-surface proteins such as cytokines and cytokine receptors. The identification and characterization of ADAM33, a putative asthma susceptibility gene identified by positional cloning in an outbred population, should provide insights into the pathogenesis and natural history of this common disease.